Previously, using genomic microarray analysis of paired (non-recurrent and recurrent) resected tumor tissues obtained from breast cancer patients [24], activation of the BDNF pathway has been found to be crucial to the clinical recurrence of TNBC tumors (Table 1). Here, BDNF is linked to breast cancer.